U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C7H4NO3S.Na.2H2O
Molecular Weight 241.197
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SACCHARIN SODIUM

SMILES

O.O.[Na+].O=C1[N-]S(=O)(=O)C2=C1C=CC=C2

InChI

InChIKey=AYGJDUHQRFKLBG-UHFFFAOYSA-M
InChI=1S/C7H5NO3S.Na.2H2O/c9-7-5-3-1-2-4-6(5)12(10,11)8-7;;;/h1-4H,(H,8,9);;2*1H2/q;+1;;/p-1

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including http://www.diabetes.co.uk/sweeteners/saccharin.html http://www.ukfoodguide.net/e954.htm

Saccharin is the most established of the artificial sweeteners on the market, this mixture of dextrose and saccharin has been in use for over a century and is found in diet versions of soft drinks. It is 300-500 times sweeter than sugar and contains zero calories. In 1977, the FDA tried to ban its use after evidence showed it caused cancer in rats. Extensive lobbying by the diet food industry allowed products to stay on the shelves as long as they carried warnings about the cancer risks in animals. This warning was removed in 2001 when the Calorie Control Council insisted the link between animal and human cancers could not automatically be made. Consumption of saccharin-sweetened products can benefit diabetics as the substance goes directly through the human digestive system without being digested. While saccharin has no food energy, it can trigger the release of insulin in humans due to its sweet taste. The T1R2/R3 sweet taste receptor exist on the surface of pancreatic beta cells. Saccharin is a unique in that it inhibits glucose-stimulated insulin secretion (GSIS) at submaximal and maximal glucose concentrations, with the other sweeteners having no effect. Investigation of saccharin’s dose-response characteristics showed that concentrations of 0.1 and 0.5 mM stimulated insulin secretion, while concentrations of 1 and 2.5 mM inhibited insulin secretion. Saccharin’s effect on insulin secretion was shown to be reversible in INS-1 832/13 clonal pancreatic beta cells after chronic exposure to 1 mM saccharin. Artificial sweeteners may affect insulin secretion via interaction with the sweet taste receptor, also saccharin may affect other cellular processes linked to insulin secretion, and that these effects are both time- and concentration-dependent

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: Q8TE23
Gene ID: 80834.0
Gene Symbol: TAS1R2
Target Organism: Homo sapiens (Human)
Target ID: Q7RTX0
Gene ID: 83756.0
Gene Symbol: TAS1R3
Target Organism: Homo sapiens (Human)
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
14 μg/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FED
27 μg/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
5800 μg × min/mL
10 mg/kg single, intravenous
dose: 10 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered: PROBENECID
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
3700 μg × min/mL
10 mg/kg single, intravenous
dose: 10 mg/kg
route of administration: Intravenous
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: UNKNOWN
6500 μg × min/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FED
6800 μg × min/mL
2 g single, oral
dose: 2 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SACCHARIN plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer



Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
no
no (co-administration study)
Comment: coadministration with bupropion: had no effect on the CYP2B activity
no
no (co-administration study)
Comment: coadministration with bupropion: saccharin had no inhibitory effect on CYP2B activity in vivo
Drug as victim

Drug as victim

TargetModalityActivityMetaboliteClinical evidence
no
PubMed

PubMed

TitleDatePubMed
Elevated expression of glucose transporter-1 in hypothalamic ependymal cells not involved in the formation of the brain-cerebrospinal fluid barrier.
2001
Serial changes in 14C-deoxyglucose and 201Tl uptake in autoimmune myocarditis in rats.
2001 Feb
Na+-to-sugar stoichiometry of SGLT3.
2001 Feb
Golgi complex, endoplasmic reticulum exit sites, and microtubules in skeletal muscle fibers are organized by patterned activity.
2001 Feb 1
Anti-tumor immunity provided by a synthetic multiple antigenic glycopeptide displaying a tri-Tn glycotope.
2001 Feb 15
GLUT4--at the cross roads between membrane trafficking and signal transduction.
2001 Jan
Suppression of ethanol responding by centrally administered CTOP and naltrindole in AA and Wistar rats.
2001 Jan
What's the truth about the health risks of sugar substitutes such as saccharin and aspartame?
2001 Jan
The rate-limiting step for tumor [18F]fluoro-2-deoxy-D-glucose (FDG) incorporation.
2001 Jan
High-resolution genetic mapping of the saccharin preference locus (Sac) and the putative sweet taste receptor (T1R1) gene (Gpr70) to mouse distal Chromosome 4.
2001 Jan
Improved diabetic syndrome in C57BL/KsJ-db/db mice by oral administration of the Na(+)-glucose cotransporter inhibitor T-1095.
2001 Jan
The synaptic vesicle protein, cysteine-string protein, is associated with the plasma membrane in 3T3-L1 adipocytes and interacts with syntaxin 4.
2001 Jan
Expression of auxilin or AP180 inhibits endocytosis by mislocalizing clathrin: evidence for formation of nascent pits containing AP1 or AP2 but not clathrin.
2001 Jan
Developmental reprogramming of rat GLUT-5 requires de novo mRNA and protein synthesis.
2001 Jan
Cellular responses of NG108-15 and SK-N-MC lines to sweet and bitter tastants as measured by extracellular acidification rates.
2001 Jan 1
Motivational effects of ethanol in DARPP-32 knock-out mice.
2001 Jan 1
Polysaccharides of green Arabica and Robusta coffee beans.
2001 Jan 15
Engineering conformational flexibility in the lactose permease of Escherichia coli: use of glycine-scanning mutagenesis to rescue mutant Glu325-->Asp.
2001 Jan 23
Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract.
2001 Mar
Hormonal regulation of chicken intestinal NHE and SGLT-1 activities.
2001 Mar
Model of the 3-D structure of the GLUT3 glucose transporter and molecular dynamics simulation of glucose transport.
2001 Mar 1
Patents

Sample Use Guides

In Vivo Use Guide
no more than 80 to 3000 mg saccharin per kilogram or litre should be used
Route of Administration: Oral
In Vitro Use Guide
After assaying for prolactin (PRL) in saccharin-treated cultures, it was observed that this sweetener is also capable of stimulating PRL production two- to sixfold in a dose-dependent manner. Enhancement of PRL production can be observed at 0.5 mM saccharin, yet this is 10 times less than the saccharin concentration required to alter cell shape. These effects of saccharin on cell morphology and on PRL production are reversible in rat pituitary tumor cells (GH4C1). When added to cultures along with maximal concentrations of epidermal growth factor (EGF) or thyrotropin-releasing hormone (TRH), the effects of saccharin on PRL production are additive, suggesting that the actions of saccharin are mediated by a somewhat different pathway from that of the peptide hormones
Name Type Language
SACCHARIN SODIUM
USP   VANDF  
Common Name English
SACCHARIN SODIUM [USP MONOGRAPH]
Common Name English
SACCHARIN SODIUM DIHYDRATE [II]
Common Name English
CRYSTALLOSE
Brand Name English
1,2-BENZISOTHIAZOL-3(2H)-ONE, 1,1-DIOXIDE, SODIUM SALT, DIHYDRATE
Common Name English
DAGUTAN
Brand Name English
1,2-Benzisothiazolin-3-one 1,1-dioxide sodium salt dihydrate
Common Name English
SUCROMAT
Brand Name English
KRISTALLOSE
Brand Name English
SODIUM SACCHARIN DIHYDRATE
Common Name English
SODIUM SACCHARIN [INCI]
Common Name English
SACCHARIN SODIUM [USP-RS]
Common Name English
SACCHARIN SODIUM, DIHYDRATE [WHO-IP]
Common Name English
SACCHARIN SODIUM SALT DIHYDRATE [MI]
Common Name English
INS NO.954(IV)
Code English
SACCHARIN SODIUM HYDRATE
JAN  
Common Name English
SACCHARIN SODIUM DIHYDRATE
II  
Common Name English
E-954(IV)
Code English
SACCHARIN SODIUM [VANDF]
Common Name English
SACCHARINUM NATRICUM, DIHYDRATE [WHO-IP LATIN]
Common Name English
SACCHARIN SODIUM HYDRATE [JAN]
Common Name English
INS-954(IV)
Code English
SODIUM SACCHARIN
INCI  
INCI  
Official Name English
Classification Tree Code System Code
CODEX ALIMENTARIUS (GSFA) INS-594(IV)
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
JECFA EVALUATION INS-954(IV)
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
NCI_THESAURUS C283
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
Code System Code Type Description
EVMPD
SUB12571MIG
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
EVMPD
SUB31113
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
DRUG BANK
DBSALT002240
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
EPA CompTox
DTXSID60904757
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
DAILYMED
SB8ZUX40TY
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
ChEMBL
CHEMBL2219743
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
RXCUI
1305723
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
CAS
6155-57-3
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
SMS_ID
100000115791
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
RXCUI
281678
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
ALTERNATIVE
NCI_THESAURUS
C76516
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
PUBCHEM
517320
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
SACCHARIN SODIUM
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY Description: Colourless crystals or a white, crystalline powder; odourless or almost odourless. Solubility: Freely soluble in water; sparingly soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Sweetening agent. Storage: Saccharin sodium should be kept in a well-closed container. Additional information: Saccharin sodium effloresces slowly in air and loses about half of its content of water of crystallization. It has a very sweet taste, even in very dilute solutions.Requirements: Saccharin sodium contains not less than 98.0% and not more than the equivalent of 101.0% of C7H4NNaO3S, calculated with reference to the anhydrous substance.
RS_ITEM_NUM
1607040
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
MERCK INDEX
m9715
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY
FDA UNII
SB8ZUX40TY
Created by admin on Fri Dec 15 15:47:15 GMT 2023 , Edited by admin on Fri Dec 15 15:47:15 GMT 2023
PRIMARY